Please Note: This trial is no longer enrolling new participants
A Single-Arm, Phase 2 Study of Neoadjuvant Carboplatin and Mirvetuximab Soravtansine in Subjects with FRa-Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
| Protocol No. | CTO-GOG-3115 | Scope | National |
|---|---|---|---|
| Principal Investigator | Jessica Parker Metter | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
